SCHEMBL20535152

SCHEMBL20535152

CC(C)(CCC(=O)O)c1ccccc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
ADRA1A P35348 1/20 0.42
OPRK1 P41145 1/20 0.42
KCNH2 Q12809 1/20 0.42
ALDH1A1 P00352 2/20 0.41
ESR1 P03372 1/20 0.41
CYP3A4 P08684 1/20 0.41
ESR2 Q92731 1/20 0.41
KDM4A O75164 1/20 0.41
KDM5A P29375 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
KDM5B Q9UGL1 1/20 0.41
PTGFR P43088 6/20 0.40
AKR1B1 P15121 1/20 0.39
HTT P42858 1/20 0.38
KIF11 P52732 1/20 0.38
KCNN4 O15554 1/20 0.38
CYP2C19 P33261 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10916792 0.82 CYP2C19 (0.48) HTR2AHTR2CADRA1AOPRK1KCNH2
SCHEMBL21632147 0.81 PTGFR (0.44) HTR2AHTR2CADRA1AOPRK1KCNH2
SCHEMBL21632134 0.80 HTR2A (0.38) HTR2AHTR2CADRA1AOPRK1KCNH2
SCHEMBL20535148 0.78 PTGFR (0.43) ALDH1A1ESR1CYP3A4ESR2PTGFR
SCHEMBL27990042 0.77 PTGFR (0.38) HTR2AHTR2CADRA1AOPRK1KCNH2
SCHEMBL4823384 0.76 FEN1 (0.45) HTR2AHTR2CADRA1AOPRK1KCNH2
SCHEMBL1682512 0.76 HIF1A (0.53) ADRA1AALDH1A1ESR1CYP3A4ESR2
SCHEMBL18516974 0.76 HTR2A (0.40) HTR2AHTR2CADRA1AOPRK1KCNH2
SCHEMBL11097563 0.76 FFAR1 (0.38) HTR2AHTR2CADRA1AOPRK1KCNH2
SCHEMBL21632132 0.75 PTGFR (0.46) HTR2AHTR2CADRA1AOPRK1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed
WO-2018189011-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2018-10-18 WO disclosed